Chem-Is-Try Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.48 M
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -622.65%
- Ebitda -672.96%
- Net Worth -5.37%
- Total Assets 0.87%
About Chem-Is-Try Life Science
Chem-Is-Try Life Science Private Limited (CLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 December 2012 and has a history of 12 years and one month. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.48 M, as per Ministry of Corporate Affairs (MCA) records.
Chandra Vyas, Prafulla Porwal, and Shankar Porwal serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232MP2012PTC029792
-
Company No.
029792
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Chem-Is-Try Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandra Vyas
|
Director | 26-Dec-2012 | Current |
Prafulla Porwal
|
Director | 26-Dec-2012 | Current |
|
Shankar Porwal
|
Director | 30-Aug-2017 | Current |
Financial Performance of Chem-Is-Try Life Science.
Chem-Is-Try Life Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 622.65% decrease in profit. The company's net worth dipped by a decrease of 5.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chem-Is-Try Life Science?
In 2019, Chem-Is-Try Life Science had a promoter holding of 52.63% and a public holding of 47.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Prakharshree Design India LlpChandra Vyas is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chem-Is-Try Life Science?
Unlock and access historical data on people associated with Chem-Is-Try Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chem-Is-Try Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chem-Is-Try Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.